Guidance remains unchanged, with management projecting "over $100 million in partnership inflows by the end of 2026" and targeting a cash burn below $390 million in 2026. The company anticipates a ...

Blockstream has announced the public release of Simplicity, a purpose-built smart contracting language now live on the Liquid ...

This year, the 16 th edition of the Anibar International Film Festival tackled the present, one marked by deepening precarity ...

Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

Recursion reported second-quarter revenue of $19.22 million, beating analyst estimates of $16.23 million, according to ...

It's common for clinical-stage biotech companies to post net losses, but the market wasn't forgiving of this one's latest.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating ...

Recursion Pharmaceuticals RXRX, a TechBio company that decodes biology and chemistry to industrialize drug discovery, is ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Tuesday reported a loss of $171.9 million in its second quarter. On a per-share basis, the Salt Lake City-based ...

Lantern Pharma Inc. (NASDAQ: LTRN), a pioneering artificial intelligence company transforming oncology drug discovery and development, today announced the public release of its AI module for ...

The Triad Business Journal features local business news about Greensboro/Winston-Salem. We also provide tools to help businesses grow, network and hire.

Hosted by Meghna Chakrabarti, On Point is a unique, curiosity-driven combination of original reporting, newsmaker interviews, first-person stories, and in-depth analysis, making the world more ...